Approval for the addition of the starflex vsd occluder in three sizes.  The device, as modified, will be marketed under the trade name starflex septal occluder and is indicated for use in patients with a complex ventricular septal defect (vsd) of a significant size to warrant closure, but that based on location, cannot be closed with standard transatrial or transarterial approaches.